Sign in to view content

Subgroup Analyses of the Phase 1 DAVIO Trial of EYP-1901 Showing Reduced Treatment Burden in Wet Age-related Macular Degeneration

Philip P Storey, MD, MPH

Video
Published 2023

Related

2-Year Outcomes From Randomized Trials of Anti-VEGF Treatments for Diabetic Retinopathy (DR) and Diabetic Macular Edema (DME)
Geeta A. Lalwani, MD
Annual Meeting Talks
2018
Office Based Flicker ERG for Monitoring the Course of CRVO and HRVO Treated With Intravitreal Anti-VEGF and Suprachoroidal Triamcinolone Therapy
John J. Wroblewski, MD
Annual Meeting Talks
2021
BiWeekly Anti-VEGF Dosing for Chronic Refractory Neovascular Age-Related Macular Degeneration Unresponsive to Standard Monthly Dosing
Eric W Schneider, MD
Updates from the Field
2019

Category: AMD-Neovascular

See more